HIV-1 Transcriptional Activator Tat Inhibits IL2 Expression by Preventing the Presence of Pol II on the IL2 Promoter
Biomolecules · 24.05.2023 · 13 (6) · 881
DOI: 10.3390/biom13060881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 24.05.2023. Verfasst von Spyridoula Anastasopoulou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunohematology, Division of Hematology, Department of Internal Medicine, Medical School, University of Patras, GR-26500 Patras, Greec…. Hauptthemen laut MEDLINE: HIV Infections, HIV-1, Interleukin-2, RNA Polymerase II. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hellenic Institute of State Scholarships (IKY).
Abstract (Originalsprache)
HIV-1 infection leads to a gradual loss of T helper cells, chronic immune activation, and eventual immune system breakdown. HIV-1 causes deregulation of the expression of IL-2, a cytokine important for T helper cell growth and survival, which is downregulated in HIV-1 patients. The present study addresses the regulation of IL2 expression via HIV-1 Tat transcriptional activator. We used J-LAT cells, a T cell line that serves as a latency model for studies of HIV-1 expression in T cells, and as controls a T cell line lacking HIV-1 elements and a T cell line with a stably integrated copy of the HIV-1-LTR promoter. We show that endogenously expressed Tat inhibits IL2 transcription in J-Lat cells via its presence in the ARRE-1/2 elements of the IL2 promoter and that the inhibition of IL2 expression is mediated by Tat inhibiting Pol II activity at the IL2 promoter, which is mediated by preventing the presence of Pol II at the ARRE-1/2 elements. Overall, Tat is present at the IL2 promoter, apart from its cognate HIV-1 LTR target. This supports our current knowledge of how HIV-1 affects the host transcriptional machinery and reflects the potential of Tat to disrupt transcriptional regulation of host genes to manipulate cell responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Immunohematology, Division of Hematology, Department of Internal Medicine, Medical School, University of Patras, GR-26500 Patras, Greece.
ORCID-Profile: Athanasia Mouzaki
Förderung
- Hellenic Institute of State Scholarships (IKY)
Zitieren
APA
Anastasopoulou, S., Georgakopoulos, T., & Mouzaki, A. (2023). HIV-1 Transcriptional Activator Tat Inhibits IL2 Expression by Preventing the Presence of Pol II on the IL2 Promoter. Biomolecules, 13(6), 881. https://doi.org/10.3390/biom13060881
Vancouver
Anastasopoulou S, Georgakopoulos T, Mouzaki A. HIV-1 Transcriptional Activator Tat Inhibits IL2 Expression by Preventing the Presence of Pol II on the IL2 Promoter. Biomolecules. 2023;13(6):881. doi:10.3390/biom13060881
BibTeX
@article{Anastasopoulou2023,
author = {Anastasopoulou, Spyridoula and Georgakopoulos, Tassos and Mouzaki, Athanasia},
title = {HIV-1 Transcriptional Activator Tat Inhibits IL2 Expression by Preventing the Presence of Pol II on the IL2 Promoter},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {6},
pages = {881},
doi = {10.3390/biom13060881}
}
EUVIMED